[Radiotherapy of hidradenitis suppurativa--still valid today?].

Abstract

PURPOSE:

In a retrospective analysis the efficacy of radiotherapy in the treatment of hidradenitis suppurativa was assessed.

PATIENTS AND METHODS:

Data from 231 patients undergoing radiotherapy for hidradenitis suppurativa in the last years in 2 hospitals were analyzed. The patients were treated with an orthovoltage therapy unit with 175 kV, 0.5 mm copper-filtering. The single doses reached from 0.5 Gy to 1.5 Gy up to total doses between 3.0 Gy and 8.0 Gy in one series. In chronic recurrent disease 2 or more series with a total dose of more than 10.0 Gy were given.

RESULTS:

Complete relief of symptoms at the end of radiotherapy was achieved in 89 patients (38%). In 92 patients (40%) there was clear improvement of symptoms. Only 2 patients did not react to radiotherapy. No side effects of radiotherapy occurred.

CONCLUSION:

Radiotherapy should be given more consideration as a treatment option for hidradenitis suppurativa.

• Authors: D Fröhlich, D Baaske, M Glatzel
• Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 176 Issue 6 Pg. 286-9 (Jun 2000) ISSN: 0179-7158 [Print] Germany
• Vernacular Title: Strahlentherapie der Hidradenitis axillaris--heute noch aktuell?
• PMID: 10897256 (Publication Type: English Abstract, Journal Article, Multicenter Study)

Topics

• Adult
• Aged
• Female
• Follow-Up Studies
• Hidradenitis Suppurativa (radiotherapy)
• Humans
• Male
• Middle Aged
• Radiotherapy Dosage
• Retrospective Studies
• Treatment Outcome